Corticosteroids (dexamethasone versus intravenous methylprednisolone) in patients with tuberculous meningitis

Annals of Tropical Medicine and Parasitology

Volumn 103, Issue 7, 2009, Pages 625-634

  Malhotra, H S ^a   Garg, R K ^a   Singh, M K ^a   Agarwal, A ^a   Verma, R ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; DEXAMETHASONE; ETHAMBUTOL; ISONIAZID; MANNITOL; METHYLPREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATAXIA; BACTERIUM CULTURE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY SEVERITY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; NEUROLOGIC DISEASE; NYSTAGMUS; OPHTHALMOSCOPY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEDATION; SEIZURE; SIDE EFFECT; SURVIVAL RATE; TOXIC HEPATITIS; TREATMENT DURATION; TUBERCULOMA; TUBERCULOUS MENINGITIS; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; CHEMOTHERAPY, ADJUVANT; CONFIDENCE INTERVALS; DEXAMETHASONE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INDIA; INJECTIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS, MENINGEAL; YOUNG ADULT;

EID: 73449140469     PISSN: 00034983     EISSN: 13648594     Source Type: Journal    
DOI: 10.1179/000349809X12502035776315     Document Type: Article

References (15)

1. Anon. (1948). Streptomycin treatment of tuberculous meningitis. British Medical Journal, 1, 582-597.
2. Bonita, R. & Beaglehole, R. (1988). Modification of Rankin scale: recovery of motor function after stroke. Stroke, 19, 1497-1500.
3. Dastur, D. K., Manghani, D. K. & Udani, P. M. (1995). Pathology and pathogenetic mechanisms in neurotuberculosis. Radiologic Clinics of North America, 33, 733-752.
4. Hirotani, M., Yabe, I., Hamada, S., Tsuji, S., Kikuchi, S. & Sasaki, H. (2007). Abnormal brain MRI signals in the splenium of the corpus callosum, basal ganglia and internal capsule in a suspected case with tuberculous meningitis. Internal Medicine, 46, 505-509.
5. Hosoglu, S., Geyik, M. F., Balik, I., Aygen, B., Erol, S., Aygencel, T. G., Mert, A., Saltoglu, N., Dokmetas, I., Felek, S., Sunbul, M., Irmak, H., Aydin, K., Kokoglu, O. F., Ucmak, H., Altindis, M. & Loeb, M. (2002). Predictors of outcome in patients with tuberculous meningitis. International Journal of Tuberculosis and Lung Disease, 6, 64-70.
6. Michael, J. S., Lalitha, M. K., Cherian, T., Thomas, K., Mathai, D., Abraham, O. C. & Brahmadathan, K. N. (2002). Evaluation of polymerase chain reaction for rapid diagnosis of tuberculous meningitis. Indian Journal of Tuberculosis, 49, 133-137.
7. Nagarathna, S., Rafi, W., Veenakumari, H. B., Mani, R., Satishchandra, P. & Chandramuki, A. (2008). Drug susceptibility profiling of tuberculous meningitis. International Journal of Tuberculosis and Lung Disease, 12, 105-107.
8. Nagesh Babu, G., Kumar, A., Kalita, J. & Misra, U. K. (2008). Proinflammatory cytokine levels in the serum and cerebrospinal fluid of tuberculous meningitis patients. Neuroscience Letters, 436, 48-51.
9. Prasad, K. & Singh, M. B. (2008). Corticosteroids for Managing Tuberculous Meningitis. The Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No. CD002244. Chichester, U.K.: John Wiley & Sons.
10. Rock, R. B., Olin, M., Baker, C. A., Molitor, T. W. & Peterson, P. K. (2008). Central nervous system tuberculosis: pathogenesis and clinical aspects. Clinical Microbiology Reviews, 21, 243-261.
11. Thwaites, G. E., Nguyen, D. B., Nguyen, H. D., Hoang, T. Q., Do, T. T., Nguyen, T. C., Nguyen, Q. H., Nguyen, T. T., Nguyen, N. H., Nguyen, T. N., Nguyen, N. L., Nguyen, H. D., Vu, N. T., Cao, H. H., Tran, T. H., Pham, P. M., Nguyen, T. D., Stepniewska, K., White, N. J., Tran, T. H. & Farrar, J. J. (2004). Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. New England Journal of Medicine, 351, 1741-1751.
12. Thwaites, G. E., Lan, N. T., Dung, N. H., Quy, H. T., Oanh, D. T., Thoa, N. T., Hien, N. Q., Thuc, N. T., Hai, N. N., Bang, N. D., Lan, N. N., Duc, N. H., Tuan, V. N., Hiep, C. H., Chau, T. T., Mai, P. P., Dung, N. T., Stepniewska, K., White, N. J., Hien, T. T. & Farrar, J. J. (2005). Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. Journal of Infectious Diseases, 192, 79-88.
13. Thwaites, G. E., Macmullen-Price, J., Tran, T. H., Pham, P. M., Nguyen, T. D., Simmons, C. P., White, N. J., Tran, T. H., Summers, D. & Farrar, J. J. (2007). Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study. Lancet Neurology, 6, 230-236.
14. World Health Organization (2003). International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Geneva: WHO.
15. World Health Organization (2004). Magnitude and Causes of Visual Impairment. Fact Sheet No. 282. Geneva: WHO.